ONE CREATION Cooperative has invested CHF 700,000 in SteriLux SA, a Swiss medical technology startup focused on innovative low-temperature sterilization solutions for medical devices.
Information on the Target
ONE CREATION Cooperative is pleased to announce an investment of CHF 700,000 in a new venture, SteriLux SA. Founded in 2014, SteriLux is a Swiss medical technology startup that has transitioned from product development to market entry. The company has created a device capable of low-temperature sterilization for medical devices made from various materials, all while maintaining a low energy consumption profile.
As the number of minimally invasive surgeries continues to rise, there is an increasing demand for complex medical devices composed of heat-sensitive materials. Current sterilization units are struggling to effectively and economically sterilize these new products. In an industry where existing technology is outdated due to a lack of innovation, SteriLux is determined to revolutionize how healthcare professionals tackle infection control.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Switzerland
The Swiss medical technology industry is recognized for its cutting-edge advancements and innovation. With a strong focus on quality and compliance, the sector is experiencing consistent growth dr
Similar Deals
Navus Ventures → Cultivated Biosciences
2024
ONE CREATION Coopérative
invested in
SteriLux SA
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $1M